Showing 1 - 18 results of 18 for search 'David, A.D.', query time: 0.06s
Refine Results
-
1
-
2
-
3
The Origins and Functions of Tissue-Resident Macrophages in Kidney Development by David A. D. Munro, Jeremy Hughes
Published 2017-10-01
Article -
4
-
5
-
6
-
7
Measure Twice, Cut Once∗ by David A. D’Alessandro, MD, Gus J. Vlahakes, MD
Published 2021-05-01
Article -
8
-
9
An experimental model of contusion injury in humans. by Matthew J Barnes, Dominic Lomiwes, David A D Parry, Stephen Mackintosh
Published 2022-01-01
Article -
10
-
11
Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease by Simone Rolfes, David A.D. Munro, Ekaterini-Maria Lyras, Eduardo Matute, Koliane Ouk, Christoph Harms, Chotima Böttcher, Josef Priller
Published 2020-10-01
Article -
12
-
13
-
14
-
15
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program by Stephen J. Nicholls, Santiago Tofé, Carel W. le Roux, David A. D’Alessio, Russell J. Wiese, Imre Pavo, Katelyn Brown, Govinda J. Weerakkody, Meltem Zeytinoglu, Irene C. Romera
Published 2024-02-01
Article -
16
Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): a single-centre, parallel-arm, randomised, placebo-control... by Jason Z. Qu, Ariel Mueller, Tina B. McKay, M. Brandon Westover, Kenneth T. Shelton, Shahzad Shaefi, David A. D'Alessandro, Lorenzo Berra, Emery N. Brown, Timothy T. Houle, Oluwaseun Akeju
Published 2023-02-01
Article -
17
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept by Tamer Coskun, Kyle W. Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B. Bokvist, Xuewei Cui, Daniel A. Briere, Over Cabrera, William C. Roell, Uma Kuchibhotla, Julie S. Moyers, Charles T. Benson, Ruth E. Gimeno, David A. D'Alessio, Axel Haupt
Published 2018-12-01
Article -
18
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist by Francis S. Willard, Jonathan D. Douros, Maria B.N. Gabe, Aaron D. Showalter, David B. Wainscott, Todd M. Suter, Megan E. Capozzi, Wijnand J.C. van der Velden, Cynthia Stutsman, Guemalli R. Cardona, Shweta Urva, Paul J. Emmerson, Jens J. Holst, David A. D’Alessio, Matthew P. Coghlan, Mette M. Rosenkilde, Jonathan E. Campbell, Kyle W. Sloop
Published 2020-09-01
Article